Tevogen Bio CEO congratulates Lynne Patton for her new appointment under President Trump.

From GlobeNewswire: 2025-01-27 14:24:33

Tevogen Bio congratulates Lynne Patton on her appointment as Deputy Assistant to the President and Director of Minority Outreach. Patton will focus on building support from Blacks, Latinos, and Women for President Trump. Previously, she served in various roles at HUD, working to bring reform and accountability to housing issues. Tevogen Bio, a clinical-stage specialty immunotherapy company, supports Patton’s bipartisan efforts and aims to advance affordable medical innovation. The company is focused on developing precision T cell therapies for infectious diseases, cancers, and neurological disorders, with positive safety data from its proof-of-concept clinical trial.

Patton’s appointment as Deputy Assistant to the President and Director of Minority Outreach is seen as an opportunity to address important issues impacting all Americans, particularly underserved communities. Tevogen Bio, a pioneering AI biotech company, is committed to supporting the President’s initiative to advance affordable medical innovation. The company is focused on developing precision T cell therapies for infectious diseases, cancers, and neurological disorders. Tevogen Bio has reported positive safety data from its proof-of-concept clinical trial and owns key intellectual property assets related to artificial intelligence.



Read more at GlobeNewswire: Tevogen Bio CEO Congratulates Lynne Patton on Being